High-risk individuals, such as those suffering from severe GI diseases, pancreatitis, or diabetic retinopathy in the past, should consult a healthcare professional prior to using retatrutide
Were proud to be able to offer the most innovative treatments at launch, with the highest quality care, nationwide. Despite GLP-1s being available for years, there are still so many people holding back from treatment due to stigma, lack of access, or concern over how the medication will fit into their lifestyle, said Laura Steele, Group Vice President of U.S
Do not exceed 8 shots per month
You may know whether nausea hits after injection
(2023) GLP-1/glucagon receptor co-agonism for the treatment of obesity Diabetology 66(7):1281-1294
It is usually administered via subcutaneous injection in controlled cycles